How many 8-K filings has Streamex Corp. filed?

Streamex Corp. (STEX) has 50 8-K (Current Event Report) filings on record, spanning Jan 2024 to Mar 2026.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Streamex Corp. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Streamex Corp. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Streamex Corp. (STEX) — 8-K Filings

All 8-K filings from Streamex Corp.. Browse 50 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (50)

Streamex Corp. Files 8-K for Material Agreement — Mar 27, 2026 Risk: medium
On March 26, 2026, Streamex Corp. entered into a material definitive agreement. The company also reported other events and filed financial statements and exhibi
Streamex Corp. Files 8-K on Director/Officer Changes & Shareholder Votes — Dec 31, 2025 Risk: medium
Streamex Corp. filed an 8-K on December 30, 2025, reporting on the departure of directors, election of new directors, appointment of officers, and compensatory
8-K Filing — Dec 19, 2025
8-K Filing — Dec 16, 2025
8-K Filing — Nov 19, 2025
8-K Filing — Nov 6, 2025
Streamex Corp. Files 8-K: Shareholder Vote, Reg FD, Financials — Nov 4, 2025 Risk: low
On November 4, 2025, Streamex Corp. filed an 8-K report detailing a submission of matters to a vote of security holders, a Regulation FD disclosure, and financi
Streamex Corp. Files 8-K with Regulatory Updates — Oct 31, 2025 Risk: low
Streamex Corp. filed an 8-K on October 31, 2025, reporting events as of October 30, 2025. The filing includes a Regulation FD Disclosure, Other Events, and Fina
Streamex Corp. Files 8-K: Material Agreement, Equity Sales — Oct 29, 2025 Risk: medium
On October 28, 2025, Streamex Corp. entered into a material definitive agreement, creating a direct financial obligation. The company also reported on unregiste
BioSig Technologies Files 8-K for Material Agreement — Sep 8, 2025 Risk: low
BioSig Technologies, Inc. filed an 8-K on September 8, 2025, reporting on a material definitive agreement. The filing indicates the company is based in Delaware
BioSig Technologies Files 8-K with Corporate Updates — Sep 5, 2025 Risk: medium
BioSig Technologies, Inc. filed an 8-K on September 5, 2025, reporting on several key events. These include the departure of directors or officers, the election
BioSig Technologies Files 8-K — Aug 13, 2025 Risk: low
BioSig Technologies, Inc. filed an 8-K on August 13, 2025, reporting an entry into a material definitive agreement and financial statements. The filing does not
BioSig Technologies Files 8-K on Material Agreement — Jul 9, 2025 Risk: medium
On July 7, 2025, BioSig Technologies, Inc. entered into a material definitive agreement, likely related to financing or operations, as indicated by the filing o
BioSig Technologies Reports Material Agreements and Acquisitions — May 30, 2025 Risk: medium
BioSig Technologies, Inc. filed an 8-K on May 30, 2025, reporting several key events as of May 27, 2025. These include entering into a material definitive agree
BioSig Technologies Files 8-K on Agreements, Equity Sales, and Officer Changes — May 27, 2025 Risk: medium
On May 23, 2025, BioSig Technologies, Inc. filed an 8-K report detailing several significant events. These include entering into a material definitive agreement
BioSig Technologies Files 8-K — May 15, 2025 Risk: low
BioSig Technologies, Inc. filed an 8-K on May 15, 2025, reporting an event on May 14, 2025. The filing is categorized under 'Other Events' and does not contain
BioSig Technologies Files 8-K — May 5, 2025 Risk: low
BioSig Technologies, Inc. filed an 8-K on May 5, 2025, reporting other events and financial statements. The filing does not contain specific details about the n
BioSig Technologies Changes Auditor to BDO USA, LLP — Apr 30, 2025 Risk: medium
BioSig Technologies, Inc. filed an 8-K on April 30, 2025, to report changes in its certifying accountant. The company has appointed BDO USA, LLP as its new inde
BioSig Sells 1M Shares for $1M in Private Placement — Apr 29, 2025 Risk: medium
On April 24, 2025, BioSig Technologies, Inc. reported an unregistered sale of equity securities. The company issued 1,000,000 shares of common stock to an inves
BioSig Technologies to Acquire PediaTrust, LLC — Mar 25, 2025 Risk: medium
BioSig Technologies, Inc. announced on March 24, 2025, that it has entered into a definitive agreement to acquire PediaTrust, LLC. The acquisition is expected t
BioSig Technologies to Acquire PediaTrust, LLC — Mar 6, 2025 Risk: medium
BioSig Technologies, Inc. announced on March 6, 2025, that it has entered into a definitive agreement to acquire PediaTrust, LLC. The acquisition is expected to
BioSig Technologies Files 8-K with Material Agreement Details — Mar 5, 2025 Risk: medium
On March 5, 2025, BioSig Technologies, Inc. filed an 8-K report detailing a material definitive agreement. The filing also includes other events and financial s
BioSig Technologies Files 8-K on Agreements and Equity Sales — Mar 3, 2025 Risk: medium
BioSig Technologies, Inc. filed an 8-K on February 28, 2025, reporting on the entry into a material definitive agreement, unregistered sales of equity securitie
BioSig Technologies Files 8-K on Director/Officer Changes & Shareholder Votes — Dec 31, 2024 Risk: medium
BioSig Technologies, Inc. filed an 8-K on December 31, 2024, reporting on several key events including the departure of directors or officers, the election of n
BioSig Technologies Files 8-K for Material Definitive Agreement — Dec 18, 2024 Risk: medium
On December 18, 2024, BioSig Technologies, Inc. entered into a material definitive agreement. The company, incorporated in Delaware with its principal executive
BioSig to Acquire PURE BIOSCIENCE for $10.5M — Dec 6, 2024 Risk: medium
BioSig Technologies, Inc. announced on December 3, 2024, that it has entered into a definitive agreement to acquire PURE BIOSCIENCE, INC. for approximately $10.
BioSig Technologies Files 8-K — Nov 13, 2024 Risk: low
BioSig Technologies, Inc. filed an 8-K on November 13, 2024, reporting other events and financial statements. The filing details the company's principal executi
BioSig Technologies to Acquire PediaTrust, LLC — Oct 29, 2024 Risk: medium
BioSig Technologies, Inc. announced on October 24, 2024, that it has entered into a definitive agreement to acquire PediaTrust, LLC. The acquisition is expected
BioSig Technologies Files 8-K Current Report — Oct 22, 2024 Risk: low
On October 18, 2024, BioSig Technologies, Inc. filed an 8-K report detailing an 'Other Event'. The filing does not specify the exact nature of the event but ind
BioSig Technologies Relocates Principal Executive Offices — Sep 13, 2024 Risk: medium
BioSig Technologies, Inc. announced on September 11, 2024, a change in its principal executive offices to 12424 Wilshire Blvd, Ste 745, Los Angeles, California,
BioSig Technologies to Acquire PediaQ for $10M — Jul 24, 2024 Risk: medium
BioSig Technologies, Inc. announced on July 23, 2024, that it has entered into a definitive agreement to acquire all outstanding shares of PediaQ, Inc. for an a
BioSig Technologies Secures $10M Financing — Jun 26, 2024 Risk: medium
On June 24, 2024, BioSig Technologies, Inc. announced the closing of a $10 million senior secured note financing with an affiliate of Lyra Capital. The notes ma
BioSig Technologies Faces Delisting Notice — Jun 11, 2024 Risk: high
BioSig Technologies, Inc. filed an 8-K on June 10, 2024, to report a notice of delisting or failure to satisfy a continued listing rule. The company is based in
BioSig Technologies Appoints New CFO, Adjusts Officer Compensation — Jun 10, 2024 Risk: medium
BioSig Technologies, Inc. announced on June 5, 2024, the appointment of Kevin T. O'Boyle as Chief Financial Officer. O'Boyle, who previously served as interim C
BioSig Technologies Files 8-K with Key Agreements and Sales — May 30, 2024 Risk: medium
On May 29, 2024, BioSig Technologies, Inc. filed an 8-K report detailing several key events. The company entered into a material definitive agreement, reported
BioSig Technologies to Acquire PediaTrust, LLC — May 28, 2024 Risk: medium
BioSig Technologies, Inc. announced on May 28, 2024, that it has entered into a definitive agreement to acquire PediaTrust, LLC. The acquisition is expected to
BioSig Technologies Announces Board Changes — May 21, 2024 Risk: low
BioSig Technologies, Inc. announced on May 20, 2024, a change in its board of directors. Specifically, the company reported the departure of a director and the
BioSig Technologies Appoints New CMO, Director — May 7, 2024 Risk: medium
BioSig Technologies, Inc. announced on May 3, 2024, the appointment of Dr. Amro Al-Khatib as Chief Medical Officer and the election of Ms. Jennifer L. Jones to
BioSig Technologies Appoints New Chief Medical Officer — May 3, 2024 Risk: medium
BioSig Technologies, Inc. announced on April 30, 2024, the appointment of Dr. Amro Al-Ali as Chief Medical Officer. Dr. Al-Ali, a practicing cardiologist, will
BioSig Technologies Appoints New CMO, Director — May 2, 2024 Risk: medium
BioSig Technologies, Inc. announced on May 2, 2024, the appointment of Dr. Amro Al-Ali as Chief Medical Officer and the election of Ms. Jennifer L. Jones to its
BioSig Technologies Faces Listing Rule Concerns — Mar 18, 2024 Risk: high
BioSig Technologies, Inc. filed an 8-K on March 18, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, with the e
BioSig Technologies Enters Material Definitive Agreement — Mar 12, 2024 Risk: medium
On March 7, 2024, BioSig Technologies, Inc. entered into a material definitive agreement, the specifics of which are detailed in this Form 8-K filing. The compa
BioSig Technologies Faces Delisting Concerns — Mar 11, 2024 Risk: high
BioSig Technologies, Inc. filed an 8-K on March 11, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule as of March 5, 2024. Th
BioSig Technologies Reports Executive Changes and Compensation Adjustments — Feb 28, 2024 Risk: medium
BioSig Technologies, Inc. filed an 8-K on February 27, 2024, reporting on the departure of directors or certain officers, election of directors, appointment of
BioSig Technologies Reports Executive Changes and Compensation Adjustments — Feb 21, 2024 Risk: medium
BioSig Technologies, Inc. filed an 8-K on February 21, 2024, reporting an event on February 15, 2024, concerning the departure of directors or certain officers,
BioSig Confirms NASDAQ Listing for Common Stock — Feb 6, 2024
BioSig Technologies, Inc. filed an 8-K on February 6, 2024, primarily to disclose that its common stock, with a par value of $0.001 per share, is registered on
BioSig Reports Exit Costs, Officer Changes on Jan 28 — Feb 1, 2024
BioSig Technologies, Inc. filed an 8-K on February 1, 2024, reporting events from January 28, 2024. The filing indicates "Cost Associated with Exit or Disposal
BioSig Technologies Reports Material Modifications to Security Holder Rights — Jan 31, 2024
BioSig Technologies, Inc. filed an 8-K on January 31, 2024, to report material modifications to the rights of security holders and amendments to its Articles of
BioSig Confirms NASDAQ Listing for Common Stock — Jan 30, 2024
BioSig Technologies, Inc. filed an 8-K on January 30, 2024, to disclose that its Common Stock, with a par value of $0.001 per share, continues to be registered
BioSig Sells $1M in Stock & Warrants to Institutional Investor — Jan 12, 2024
On January 12, 2024, BioSig Technologies, Inc. (BSGM) entered into a definitive agreement to sell 1,000,000 shares of its common stock and warrants to purchase

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX